Genetic markers for ovarian cancer risk: are we close to seeing a clinical impact?
Publication
, Journal Article
Moorman, PG
Published in: Per Med
August 2012
Duke Scholars
Published In
Per Med
DOI
EISSN
1744-828X
Publication Date
August 2012
Volume
9
Issue
6
Start / End Page
565 / 567
Location
England
Related Subject Headings
- Pharmacology & Pharmacy
- 3214 Pharmacology and pharmaceutical sciences
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Moorman, P. G. (2012). Genetic markers for ovarian cancer risk: are we close to seeing a clinical impact? Per Med, 9(6), 565–567. https://doi.org/10.2217/pme.12.58
Moorman, Patricia G. “Genetic markers for ovarian cancer risk: are we close to seeing a clinical impact?” Per Med 9, no. 6 (August 2012): 565–67. https://doi.org/10.2217/pme.12.58.
Moorman PG. Genetic markers for ovarian cancer risk: are we close to seeing a clinical impact? Per Med. 2012 Aug;9(6):565–7.
Moorman, Patricia G. “Genetic markers for ovarian cancer risk: are we close to seeing a clinical impact?” Per Med, vol. 9, no. 6, Aug. 2012, pp. 565–67. Pubmed, doi:10.2217/pme.12.58.
Moorman PG. Genetic markers for ovarian cancer risk: are we close to seeing a clinical impact? Per Med. 2012 Aug;9(6):565–567.
Published In
Per Med
DOI
EISSN
1744-828X
Publication Date
August 2012
Volume
9
Issue
6
Start / End Page
565 / 567
Location
England
Related Subject Headings
- Pharmacology & Pharmacy
- 3214 Pharmacology and pharmaceutical sciences
- 3202 Clinical sciences